A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
What 'Light' Daily Cleaning of Patient Rooms Misses
Sprinkler Compliance: Navigating Code Mandates, Renovation Triggers and Patient Safety
MUSC Board of Trustees Approves $1.1B South Carolina Cancer Hospital
Study Outlines Hand Hygiene Guidelines for EVS Staff
McCarthy Completes $65M Sharp Rees-Stealy Kearny Mesa MOB Modernization